EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating long-term programmatic outcomes of patients with advanced HIV disease: Insights from 12 years of antiretroviral therapy scale-up in rural KwaZulu-Natal

Marcel K Kitenge iD, Geoffrey Fatti iD, Chinmay Laxmeshwar iD, Patrick D M C Katoto, Peter S Nyasulu

PLOS One · 2026

DOI: 10.1371/journal.pone.0360657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Marcel K Kitenge und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town,…. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advanced HIV disease (AHD) remains a significant public health challenge, despite the widespread scale-up of antiretroviral therapy (ART) in South Africa. Understanding long-term treatment outcomes among patients with AHD under routine programmatic conditions is critical. However, there is a paucity of longitudinal data on clinical outcomes in this population, particularly within high-HIV prevalence rural settings. This study evaluated retention in care and virological outcomes among patients initiating ART with AHD in rural KwaZulu-Natal between 2008 and 2020.

Methods

We conducted a retrospective cohort study using routine data from 10 public health facilities. Adults (≥18 years) with CD4 < 200 cells/μL or WHO stage 3/4 who initiated ART between January 1, 2008, and December 31, 2020, were included. Primary outcomes were retention in care at 6, 12, 24, 36, and 48 months. Secondary outcomes included viral load (VL) completion and suppression (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsHumansMaleRetrospective StudiesViral LoadFemaleAdultRural PopulationSouth AfricaCD4 Lymphocyte CountTreatment OutcomeRetention in CareMiddle Aged

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • School of Mathematics, Statistics & Computer Science, University of KwaZulu-Natal, Durban, South Africa.
  • Department of Global Health, University of Washington, Seattle, Washington, United States of America.
  • Centre for Tropical Diseases and Global Health, Department of Medicine, Catholic University of Bukavu, Bukavu, DR Congo.
  • Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

ORCID-Profile: Marcel K Kitenge, Geoffrey Fatti, Chinmay Laxmeshwar

Zitieren

APA

Kitenge, M. K., Fatti, G., Laxmeshwar, C., Katoto, P. D. M. C., & Nyasulu, P. S. (2026). Evaluating long-term programmatic outcomes of patients with advanced HIV disease: Insights from 12 years of antiretroviral therapy scale-up in rural KwaZulu-Natal. PLOS One. https://doi.org/10.1371/journal.pone.0360657

Vancouver

Kitenge MK, Fatti G, Laxmeshwar C, Katoto PDMC, Nyasulu PS. Evaluating long-term programmatic outcomes of patients with advanced HIV disease: Insights from 12 years of antiretroviral therapy scale-up in rural KwaZulu-Natal. PLOS One. 2026. doi:10.1371/journal.pone.0360657

BibTeX
@article{Kitenge2026,
  author = {Kitenge, Marcel K and Fatti, Geoffrey and Laxmeshwar, Chinmay and Katoto, Patrick D M C and Nyasulu, Peter S},
  title = {Evaluating long-term programmatic outcomes of patients with advanced HIV disease: Insights from 12 years of antiretroviral therapy scale-up in rural KwaZulu-Natal},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0360657}
}
Kostenlos starten →